---
title: "BOCOM International Holdings Company Reaffirms Their Buy Rating on Antengene Corporation Limited (722)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278233354.md"
description: "BOCOM International Holdings Company analyst maintained a Buy rating on Antengene Corporation Limited yesterday and set a price target of HK$8.80. The company’s shares closed yesterday at HK$3.91.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Antengene Corporation Limited with a €0.97 average price target."
datetime: "2026-03-07T17:45:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278233354.md)
  - [en](https://longbridge.com/en/news/278233354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278233354.md)
---

# BOCOM International Holdings Company Reaffirms Their Buy Rating on Antengene Corporation Limited (722)

BOCOM International Holdings Company analyst maintained a Buy rating on Antengene Corporation Limited yesterday and set a price target of HK$8.80. The company’s shares closed yesterday at HK$3.91.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Antengene Corporation Limited with a €0.97 average price target.

### Related Stocks

- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [06996.HK](https://longbridge.com/en/quote/06996.HK.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)

## Related News & Research

- [Xuanzhu Biopharm Wins Green Light for Phase III Anaprazole Trial in H. pylori](https://longbridge.com/en/news/282752451.md)
- [AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid](https://longbridge.com/en/news/282533515.md)
- [Sino Biopharmaceutical Unit Enrolls First Patient in Gastric Cancer Drug Trial](https://longbridge.com/en/news/282827241.md)
- [Anthropic adds Novartis CEO Vas Narasimhan to its board](https://longbridge.com/en/news/282719936.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)